Alexion to Present at the 37th Annual J.P. Morgan Healthcare Conference
BOSTON--(BUSINESS WIRE)--Jan 2, 2019--Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at the 37 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 8, 2019 at 7:30 a.m., PT. A breakout question and answer session will immediately follow the formal presentation.
Audio webcasts of the presentation and breakout question and answer session will be available live. You can access the webcasts at: http://ir.alexion.com. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190102005436/en/
Susan Altschuller, Ph.D.
Vice President, Investor Relations
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL
SOURCE: Alexion Pharmaceuticals
Copyright Business Wire 2019.
PUB: 01/02/2019 04:30 PM/DISC: 01/02/2019 04:31 PM